In aggregate, these data uncover a previously unreported role of GCP‐2 released from peritumoral senescent fibroblasts, which activate signature pathways and twisted metabolism in melanoma cells, contributing to melanoma progression. This evidence concerns the gene CXCL6 and melanoma.